153 related articles for article (PubMed ID: 10372134)
1. G-CSF receptor mutations in patients with severe congenital neutropenia do not abrogate Jak2 activation and stat1/stat3 translocation.
Herbst A; Koester M; Wirth D; Hauser H; Welte K
Ann N Y Acad Sci; 1999 Apr; 872():320-5; discussion 325-7. PubMed ID: 10372134
[TBL] [Abstract][Full Text] [Related]
2. Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia.
Ward AC; van Aesch YM; Schelen AM; Touw IP
Blood; 1999 Jan; 93(2):447-58. PubMed ID: 9885206
[TBL] [Abstract][Full Text] [Related]
3. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene.
Hermans MH; Antonissen C; Ward AC; Mayen AE; Ploemacher RE; Touw IP
J Exp Med; 1999 Feb; 189(4):683-92. PubMed ID: 9989983
[TBL] [Abstract][Full Text] [Related]
4. Dissociation of the Jak kinase pathway from G-CSF receptor signaling in neutrophils.
Avalos BR; Parker JM; Ware DA; Hunter MG; Sibert KA; Druker BJ
Exp Hematol; 1997 Feb; 25(2):160-8. PubMed ID: 9015216
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia.
Dong F; Brynes RK; Tidow N; Welte K; Löwenberg B; Touw IP
N Engl J Med; 1995 Aug; 333(8):487-93. PubMed ID: 7542747
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl terminus of the granulocyte colony-stimulating factor receptor, truncated in patients with severe congenital neutropenia/acute myeloid leukemia, is required for SH2-containing phosphatase-1 suppression of Stat activation.
Dong F; Qiu Y; Yi T; Touw IP; Larner AC
J Immunol; 2001 Dec; 167(11):6447-52. PubMed ID: 11714811
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine-dependent and -independent mechanisms of STAT3 activation by the human granulocyte colony-stimulating factor (G-CSF) receptor are differentially utilized depending on G-CSF concentration.
Ward AC; Hermans MH; Smith L; van Aesch YM; Schelen AM; Antonissen C; Touw IP
Blood; 1999 Jan; 93(1):113-24. PubMed ID: 9864153
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route.
Barge RM; de Koning JP; Pouwels K; Dong F; Löwenberg B; Touw IP
Blood; 1996 Mar; 87(6):2148-53. PubMed ID: 8630373
[TBL] [Abstract][Full Text] [Related]
9. The G-CSF receptor carboxyl terminus, truncated in AML/SCN, is required for induction of a Stat5 protease activity.
Qiu Y; Zhuang D; MacRae A; Dong F
Leuk Res; 2005 Oct; 29(10):1153-62. PubMed ID: 16111533
[TBL] [Abstract][Full Text] [Related]
10. G-CSF receptor truncations found in SCN/AML relieve SOCS3-controlled inhibition of STAT5 but leave suppression of STAT3 intact.
van de Geijn GJ; Gits J; Aarts LH; Heijmans-Antonissen C; Touw IP
Blood; 2004 Aug; 104(3):667-74. PubMed ID: 15069015
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
12. An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia.
Forbes LV; Gale RE; Pizzey A; Pouwels K; Nathwani A; Linch DC
Oncogene; 2002 Sep; 21(39):5981-9. PubMed ID: 12203110
[TBL] [Abstract][Full Text] [Related]
13. Loss of SHIP and CIS recruitment to the granulocyte colony-stimulating factor receptor contribute to hyperproliferative responses in severe congenital neutropenia/acute myelogenous leukemia.
Hunter MG; Jacob A; O'donnell LC; Agler A; Druhan LJ; Coggeshall KM; Avalos BR
J Immunol; 2004 Oct; 173(8):5036-45. PubMed ID: 15470047
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
Dong F; Dale DC; Bonilla MA; Freedman M; Fasth A; Neijens HJ; Palmblad J; Briars GL; Carlsson G; Veerman AJ; Welte K; Löwenberg B; Touw IP
Leukemia; 1997 Jan; 11(1):120-5. PubMed ID: 9001427
[TBL] [Abstract][Full Text] [Related]
15. Combined corticosteroid/granulocyte colony-stimulating factor (G-CSF) therapy in the treatment of severe congenital neutropenia unresponsive to G-CSF: Activated glucocorticoid receptors synergize with G-CSF signals.
Dror Y; Ward AC; Touw IP; Freedman MH
Exp Hematol; 2000 Dec; 28(12):1381-9. PubMed ID: 11146160
[TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor receptor mutations in severe congenital neutropenia transforming to acute myelogenous leukemia confer resistance to apoptosis and enhance cell survival.
Hunter MG; Avalos BR
Blood; 2000 Mar; 95(6):2132-7. PubMed ID: 10706885
[TBL] [Abstract][Full Text] [Related]
17. Association of src-kinase Lyn and non-src-kinase Syk with the granulocyte colony-stimulating factor receptor (G-CSFR) is not abrogated in neutrophils from severe congenital neutropenia patients with point mutations in the G-CSFR mRNA.
Kasper B; Tidow N; Welte K
Int J Hematol; 1999 Dec; 70(4):241-7. PubMed ID: 10643150
[TBL] [Abstract][Full Text] [Related]
18. Novel point mutation in the extracellular domain of the granulocyte colony-stimulating factor (G-CSF) receptor in a case of severe congenital neutropenia hyporesponsive to G-CSF treatment.
Ward AC; van Aesch YM; Gits J; Schelen AM; de Koning JP; van Leeuwen D; Freedman MH; Touw IP
J Exp Med; 1999 Aug; 190(4):497-507. PubMed ID: 10449521
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of point mutations in the cytoplasmic domain of the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
Tidow N; Pilz C; Teichmann B; Müller-Brechlin A; Germeshausen M; Kasper B; Rauprich P; Sykora KW; Welte K
Blood; 1997 Apr; 89(7):2369-75. PubMed ID: 9116280
[TBL] [Abstract][Full Text] [Related]
20. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation.
Kirito K; Nakajima K; Watanabe T; Uchida M; Tanaka M; Ozawa K; Komatsu N
Blood; 2002 Jan; 99(1):102-10. PubMed ID: 11756159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
